Ursolic acid (1), a natural pentacyclic triterpenic acid, afforded a variety of ring-C transformed products (5-11) when treated with N-bromosuccinimide under the influence of a range of protective groups and solvents. The synthesized compounds have been evaluated for cytotoxic activity against prostate PC 3, leukemia THP 1, cervical Hela and lung A-549 cancer cell lines. Among the tested analogs, compounds 5, 8, 9 and 10 showed potent activity against PC 3, THP 1 and Hela cell lines. Especially, compound 10 showed enhanced activity against the Hela cell line than the parent compound. Compounds 5, 8 and 9 showed comparable activities against PC 3 and THP 1 cell lines.
Plant derived compounds play a pivotal role in the discovery and development of new chemotherapeutic agents [1] . Among the plant derived lead compounds, pentacyclic triterpenes form an interesting group of natural scaffolds. These are amenable to a wide range of chemical transformations and elaborate numerous new chemical entities (NCEs) [2] . In this class, ursolic acid (1) assumes significance as a highly attractive structural phenotype found widespread in the plant kingdom [3] . Its interesting potent bio-activities such as anti-cancer [4] , hepatoprotective [5] , and antiinflammatory [6] , and its relatively non-toxic nature, have attracted the attention of chemists for the development of NCEs for newer and enhanced biological activities [7] . It has an olefinic system between C 12 and C 13, which makes the C 11 allylic methylene highly useful for halogenation. The C 11 halogenated compounds in turn can be used for further elaboration of ring-C. A literature search revealed that an early attempt to brominate ursolic acid with bromine in acetic acid had been unsuccessful [8] . Tkachev et al. reported the formation of lactones with or without bromine from acetylursolic acid and NBS reactions carried out at various temperatures [9] . However, this study is inconclusive and needs to be investigated in detail. It is noteworthy that some ursolic acid ring-C analogs with 12-fluoro-13,28-lactone moieties were reported recently with potent antiproliferative activity against AsPC-1 pancreatic cancer cells [10] . Keeping this background in mind, we have now carried out transformations of ring-C of ursolic acid (1) with NBS to synthesize some novel analogs by protecting either C 3 -OH or C 17 -COOH or both, and with different polar solvents. We herein report the diverse product formation from the ursolic acid-NBS reaction, carried out under various experimental conditions and the cytotoxic evaluation of the synthesized compounds using four tumor cell lines.
The protocols for the N-bromosuccinimide reactions of ursolic acid (1) are presented in Scheme 1. Initially, the unprotected ursolic acid (1) was treated with NBS in CCl 4 for 8 hours at room temperature, which afforded 3-hydroxy-urs-28→13-olide (5) in 55% yield; this compound was earlier isolated from Eucalyptus tereticornis [11] . Interestingly, the same reaction, when carried out in aq. dioxane at room temperature for 18 hours, afforded the new 3-oxo-urs-28→13olide (6) in 50% yield.
In order to see the effect of C 3 -OH on the product formation, it was protected as an acetate, and the resultant compound, 3-acetoxyurs-12-ene-28-oic acid (2) was subjected to reaction with NBS in both CCl 4 and aq. dioxane. This compound behaved similarly to compound 1 and afforded an unsaturated lactone, 3β-acetoxy-urs-11-ene-28→13-olide (7) in 60% yield when treated with CCl 4 at room temperature for 8 hours, and a saturated lactone, 3-acetoxyurs-28→13-olide (8) in 52% yield with aq. dioxane. Literature search revealed that compounds 7 and 8 were isolated earlier from the bark of Pieris japonica D. Don. [12] .
Close observation of the products formed in the above two sets of reactions revealed that lactone formation is the major transformation due to the presence of a free carboxylic acid at C 17 . In order to see the effect of C 17 protected carboxylic acid, compound 1 was converted to its methyl ester, methyl-3-hydroxyurs-12-ene-28-oate (3). Compound 3 was then subjected to NBS reaction in both CCl 4 and aq.dioxane at room temperature for 8 and 18 hours, respectively. Surprisingly, both reactions furnished the same compound in 68% and 56% yields, respectively. The compound was identified as the new methyl-3-hydroxy-urs-9(11), 12-dien-28-oate (9) .
Protection of both the C 3 -OH and C 17 -COOH is expected to give still more interesting products. Hence, methyl-3-acetoxy-urs-12ene-28-oate (4) was prepared and subjected to reaction with NBS in both CCl 4 and aq. dioxane. In CCl 4, compound 4 behaved similarly to compound 3 and afforded the new diene, methyl-3-acetoxy-urs-9(11), 12-dien-28-oate (10) in 86% yield. However, interestingly, the reaction when carried out in aq. dioxane furnished an unsaturated ketone, methyl-3-acetoxy-urs-11-oxo-12-ene-28oate (11) in 51% yield; this compound was reported earlier from the resin of Bursera delpechiana [13] .
In total 4 lactones, 2 dienes and 1 -unsaturated C-ring analogs of ursolic acid were synthesized. All the synthesized compounds were thoroughly characterized from their spectroscopic (IR, 1 H, 13 C NMR) and mass spectrometric data [11] [12] [13] . While the lactones 5-8 showed characteristic carbonyl absorptions between 1760~1703 cm -1 in their IR spectra, and lactone ring carbons at 91.66 (C 13 ), 45.04~45.50 (C 17 ), 56.13~60.51 (C 18 ) and 178.8-~178.96 (C 28 ) in their 13 C NMR spectra, the dienes 9 and 10 showed the characteristic olefinic protons as a pair of doublets at  5.51 and 5.58 in their 1 H NMR spectra, and C 9 , C 11 , C 12 and C 13 at 115, 123, 139 and 154 respectively in their 13 C NMR spectra. Compound 11, with an -unsaturated carbonyl system, showed characteristic peaks at 1650 cm -1 in its IR spectrum, and δ 199.92 (C 11 ), 163.07 (C 13 ), and 130.89 (C 12 ), in addition to C3-acetate (δ 171.20) and C17-methyl ester (δ 177.42) in its 13 C NMR spectrum. 
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Cytotoxic evaluation:
The synthesized compounds 5-11 along with the parent ursolic acid (1) were evaluated for their inhibitory activity against the growth of prostate PC 3, leukemia THP-1, cervical Hela and lung A-549 cancer cell lines using paclitaxel, mitomycin and 5-fluorouracil as positive controls [14] . All the tested compounds, including ursolic acid (1), exhibited dose dependent inhibitory activity against the four cancer cell lines. Among the tested analogs, compounds 5, 8, 9 and 10 showed considerable activity against PC 3, THP 1 and Hela. Compound 10 showed more enhanced activity (IC 50 : 44.9 g/mL) against the Hela cell line than the parent compound. Surprisingly, none of the other synthesized compounds showed better activity than the parent against this cell line. In the case of the prostate PC-3 cell line, compounds 8 & 9 were more active than compounds 5 and 10. While compound 9 showed comparable activity (IC 50 : 23.7 g/mL) with that of the parent compound, compound 8 (IC 50 : 52.2 g/mL) was ~ 2.8 times less active than the parent compound. Interestingly, compounds 8 (IC 50 : 30.3 g/mL), 9 (IC 50 : 43.3 g/mL) and 5 (IC 50 : 47.4 g/mL) exhibited significant activity against the leukemia THP-1 cell line, but were less active than the parent compound. In the case of the lung A-549 cancer cell line, none of the synthesized compounds showed comparable or enhanced activity than the parent compound, suggesting that alteration of the C-ring adversely affects the activity. From the above observations, it can be concluded that transformation of the C-ring of ursolic acid to a diene system resulted in enhancement of inhibitory activity against cervical Hela, comparable activity against prostate PC-3, and decreased activity against leukemia THP-1 cancer cell lines. However, transformation to lactones resulted in comparable activity against leukemia THP-1 and decreased activity against prostate PC-3 cell lines. The transformation to an -unsaturated carbonyl system drastically reduced the inhibitory activity on all four cell lines screened. In conclusion, we described the synthesis of some novel C-ring analogs such as lactones, dienes and unsaturated ketones of ursolic acid by reacting with NBS under the influence of various protective groups and solvents. The synthesized compounds have been evaluated for cytotoxic activity against prostate PC 3, leukemia THP 1, cervical Hela and lung A-549 cancer cell lines and found to exhibit dose dependant inhibitory activity against all four cell lines. Among the tested analogs, compounds 5, 8, 9 and 10 showed potent activity against PC 3, THP 1 and Hela cell lines. Especially, compound 10 showed enhanced activity against the Hela cell line than the parent compound. Compounds 5, 8 and 9 showed comparable activities against PC 3 and THP 1 cell lines.
Experimental
General: 1 H-and 13 C-NMR spectra were recorded on a Bruker 400 MHz spectrometer. Samples were dissolved in CDCl 3 and tetramethyl silane (TMS) was used as internal standard. The chemical shifts ( value) are expressed in parts per million downfield from tetramethyl silane ( = 0) and coupling constants (J) in Hz. Mass spectra were recorded on a Waters Synapt mass spectrometer. IR spectra were obtained on a JASCO FT-IR 5300 spectrometer using KBr pellets and wave numbers are expressed in cm -1 . Melting points were taken on a Buchi Melting-point apparatus and are uncorrected. Solvents were dried over standard drying agents and freshly distilled prior to use. For column chromatography (CC), Acme grade silica gel (100-200 mesh) and or neutral alumina were used. 4 : To a stirred solution of the compound (1, 2, 3 or 4, 0.2 mM) in CCl 4 (3 mL) was added freshly recrystallised NBS (0.3 mM) and the resultant mixture was stirred at room temperature for 8 h. The reaction mixture was filtered and concentrated under reduced pressure to yield the crude product, which on CC over neutral alumina using n-hexane-ethyl acetate gradient elution, followed by recrystallisation from methanol, afforded the respective products (5, 7, 9, 10 ).
General procedure for NBS reaction in CCl
3-Hydroxy-urs-28→13-olide (5)
Colorless feathery crystals (52 mg from 95 mg of 1 [11] .
3-Acetoxy-urs-11-ene-28→13-olide (7) Colorless needles (60 mg from 100 mg of 2 [12] .
Methyl-3-hydroxy-urs-9(11),12-dien-28-oate (9) Colorless amorphous powder (68 mg from 100 mg of 3 
General procedure for NBS reaction in aq. dioxane-CaCO 3:
Freshly recrystallised NBS (0.3 mM) was added to a stirred solution of the compound (1, 2, 3 or 4, 0.2 mM) in dioxane (3 mL). To it water (0.3 mL) was added followed by CaCO 3 (0.3 mM) and the reaction mixture was stirred at room temperature for 18 h. The reaction mixture was filtered and the resultant filtrate was diluted with ice cold water (5 mL) and extracted with ethyl acetate (3 x 5 mL). The combined organic layer was dried over anhydrous sodium sulfate and concentrated in vacuum to yield the crude product. CC over neutral alumina using n-hexane-ethyl acetate gradient elution, followed by recrystallisation from methanol, afforded the respective pure compounds (6, 8, 9, 11 ). (6) Colorless shining crystals (50 mg from 100 mg of 1 [13] .
3-Oxo-urs-28→13-olide
In vitro cytotoxicity: Cancer cells were grown in tissue culture flasks in growth medium (RPMI-1640 with 2 mM glutamine, pH 7.4, 10% fetal calf serum, 100 µg/mL streptomycin, and 100 units/mL penicillin) at 37 0 C in an atmosphere of 5% CO 2 and 95% relative humidity in a carbon dioxide incubator. The cells at the subconfluent stage were harvested from the flask by treatment with trypsin (0.05% trypsin in PBS containing 0.02% EDTA) and suspended in growth medium. Cells with more than 97% viability (trypan blue exclusion) were used for determination of cytotoxicity [14] . An aliquot (100 µL) of cells was transferred to a well of a 96-well tissue culture plate. The cells were allowed to grow for 24 h at 37 0 C in a carbon dioxide incubator as stated above. Stock solutions (20 mM) of the test compounds were prepared in DMSO. The stock solutions were serially diluted with growth medium supplemented with 50 µg/mL gentamycin to obtain solutions of desired concentrations. Test compounds (100 µL/well) were then added to the wells and cells were further allowed to grow for another 48 h. Suitable blanks and positive controls were also included. Each test was made in triplicate. The cell growth was stopped by gently layering trichloroacetic acid (50%, 50 µL/well). The plates were incubated at 4 0 C for 1 h to fix the cells attached to the bottom of the wells. Liquid of all the wells was gently pipetted out and discarded. The plates were washed 5 times with distilled water to remove trichloroacetic acid and growth medium, and were air-dried. Sulphordamine B solution (0.4% in 1% acetic acid, 100 µL/well) was added to each well and the plates were incubated at room temperature for 30 min. The unbound dye was quickly removed by washing the wells 5 times with 1% acetic acid. Plates were air dried, Tris-buffer (0.01M, pH 10.4, 100µL/well) was added to all the wells and plates were gently stirred for 5 min on a mechanical stirrer. The optical density was recorded on an ELISA reader at 540 nm. The cell growth at absence of any test material was considered 100% and in turn growth inhibition was calculated.
